InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,219.20
(
0.23%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.94
(
0.89%
)
Bitcoin
61,236.16
(
-0.93%
)
Post# of 345981
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

freethemice

Send PM Follow Ignore
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

freethemice

Re: Roger1 post# 90356

Thursday, 09/06/2012 2:44:51 PM

Thursday, September 06, 2012 2:44:51 PM

Post# of 345981
That Avastin + CP trial was for first-line NSCLC, not second-line, and the MOS wasn't 13.4 months
it was 12.3 months, and the control arm MOS was 10.3 months.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

Start posting your company's news
Only $200 per official company press release!